QRxPharma defendants can access class members’ broker details

Class Actions 2018-09-13 11:49 pm By Miklos Bolza | Sydney

The defendants in a shareholder class action over QRxPharma’s alleged failure to disclose problems with regulatory approval for its painkiller Moxduo have won access to information on class members’ financial brokers.